Balyasny Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$609K Sell
18,009
-617,060
-97% -$17.5M ﹤0.01% 2275
2025
Q4
$17.3M Buy
635,069
+139,578
+28% +$4.9M 0.03% 790
2025
Q3
$19.9M Buy
+495,491
New +$18.6M 0.04% 719
2025
Q1
Sell
-248,038
Closed -$8.15M 2745
2024
Q4
$8.15M Buy
+248,038
New +$11.7M 0.02% 1049
2024
Q3
Sell
-41,793
Closed -$1.8M 2697
2024
Q2
$1.8M Sell
41,793
-36,695
-47% -$1.32M ﹤0.01% 1569
2024
Q1
$2.29M Buy
78,488
+36,485
+87% +$977K 0.01% 1507
2023
Q4
$935K Sell
42,003
-223,034
-84% -$5M ﹤0.01% 1718
2023
Q3
$6.56M Buy
265,037
+46,937
+22% +$1.24M 0.02% 1000
2023
Q2
$6.18M Sell
218,100
-102,907
-32% -$2.56M 0.02% 984
2023
Q1
$7.37M Buy
321,007
+41,450
+15% +$1.1M 0.02% 911
2022
Q4
$7.85M Buy
+279,557
New +$7.88M 0.03% 834
2020
Q4
Sell
-89,988
Closed -$3.15M 1278
2020
Q3
$3.15M Buy
+89,988
New +$3.94M 0.03% 721
2019
Q2
Sell
-4,273
Closed -$288K 1440
2019
Q1
$288K Sell
4,273
-81,003
-95% -$4.72M ﹤0.01% 1312
2018
Q4
$3.93M Sell
85,276
-266,721
-76% -$16.5M 0.03% 551
2018
Q3
$27.1M Sell
351,997
-54,955
-14% -$4.42M 0.15% 233
2018
Q2
$34.3M Sell
406,952
-276,412
-40% -$24.1M 0.18% 178
2018
Q1
$55.9M Sell
683,364
-446,899
-40% -$34.5M 0.27% 103
2017
Q4
$64.6M Buy
1,130,263
+164,111
+17% +$10.3M 0.23% 123
2017
Q3
$64.5M Buy
966,152
+13,900
+1% +$835K 0.29% 97
2017
Q2
$49M Buy
952,252
+83,130
+10% +$4.25M 0.23% 130
2017
Q1
$50.8M Buy
869,122
+184,040
+27% +$8.82M 0.27% 107
2016
Q4
$28.6M Sell
685,082
-235,622
-26% -$12.4M 0.18% 183
2016
Q3
$48.6M Buy
920,704
+595,134
+183% +$25.9M 0.29% 115
2016
Q2
$13.6M Buy
325,570
+227,120
+231% +$11.2M 0.11% 290
2016
Q1
$4M Buy
98,450
+10,950
+13% +$468K 0.03% 591
2015
Q4
$5.68M Sell
87,500
-38,661
-31% -$2.54M 0.04% 474
2015
Q3
$8.91M Buy
+126,161
New +$12.3M 0.08% 375

Other funds holding AGIO